"South Africa Pharmaceuticals & Healthcare Report Q3 2012" Now Available at Fast Market Research
BMI View: While we remain optimistic about South Africa's longer-term commercial potential from the point of view of innovative drugmakers, a number of obstacles will remain. Private healthcare facilities remain out of reach for the vast majority of the population, while public health programmes continue to suffer from budgetary shortcomings. Moves in the right direction have been made with the creation of the National Health Insurance (NHI) scheme, with pilot programmes rolled out in April, although its implementation is not...
View full press release